Chronic prostatitis/chronic pelvic pain syndrome: The role of an antifungal regimen

Central European Journal of Urology

Volumn 66, Issue 2, 2013, Pages 196-199

  Kotb, Ahmed Fouad ^a   Ismail, Asmaa Mohamed ^a   Sharafeldeen, Mohamed ^a   Elsayed, Elsayed Yahia ^a  

^a ALEXANDRIA UNIVERSITY   (Egypt)

Author keywords

Antifungal; Candida; Chronic pelvic pain syndrome; Prostatitis

Indexed keywords

EID: 84881596117     PISSN: 20804806     EISSN: 20804873     Source Type: Journal    
DOI: 10.5173/ceju.2013.02.art21     Document Type: Article

References (17)

1. Collins MM, Stafford RS, O'Leary M P, Barry MJ. How common is prostatitis? A national survey of physician visits. J Urol. 1998; 159: 1224-1228.
2. Mahlknecht A, Pecorari V, Richter A. Sepsis due to asymptomatc Candida prostatts. Arch Ital Urol Androl. 2005; 77: 155-156.
3. Elert A, von Knoblock R, Nusser R, Heiden-reich A, Hofmann R. Isolated candidal prostatitis. J Urol. 2000; 163: 244.
4. Collado A, Ponce de Leon J, Salinas D, Salvador J, Vicente J. Prostatic abscess due to Candida with no systemic manifestations. Urol Int. 2001; 67: 186-188.
5. Indudhara R, Singh SK, Vaidyanathan S, Banerjee CK. Isolated invasive Candidal prostatitis. Urol Int. 1992; 48: 362-364.
6. Pansadoro V, Emiliozzi P, Defidio L, Scarpone P, Sabatini G, Brisciani A, Lauretti S. Prostate-specific antigen and prostatitis in men under fifty. Eur Urol. 1996; 30: 24-27.
7. Lee AG, Choi YH, Cho SY, Ch IR. A prospective study of reducing unnecessary prostate biopsy in patents with high serum prostate- specific antgen with consideration of prostatic inflammation. Korean J Urol. 2012; 53: 50-53.
8. Da Silva EH, Da Silva Ruiz L, Matsumoto FE, Auler ME, Giudice MC, Moreira D, Szeszs W, Paula CR. Candiduria in a public hospital of Sao Paulo (1999-2004): Characteristcs of the yeast isolates. Rev Med Trop. 2007; 49: 349-353.
9. Brito LR, Guimaraes T, Nucci M, Rosas RC. Paula Alemida L, Da Mata DA, Colombo AL: Clinical and microbiological aspects of candidemia due to Candida parapsilosis in Brazilian tertary care hospitals. Med Mycol. 2006; 44: 246-261.
10. Behzadi P, Behzadi E, Yazdanbod H, Aghapour R, Akbari Cheshmeh M, Salehian O.D. Urinary Tract Infectons Associated with Candida albicans. Maedica (Buchar). 2010; 5: 277-279.
11. Fisher JF, Kavanagh K, Sobel JD, Kaufman CA, Newman CA. Candida urinary tract infection: pathogenesis. Clin Infect Dis. 2011; 52 (Suppl 6): 437-451.
12. Centeno A, Davis CP, Cohen MS, Warren MM. Modulation of Candida albicans attachment to human epithelial cells by bacteria and carbohydrates. Infect Immun 1983; 39: 1354-1360.
13. Parkash C, Chugh TD, Gupta S P, Thanik KD. Candida infection of the urinary tract-an experimental study. J Assoc Physicians India. 1970; 18: 497-502.
14. Anothaisintawee T, Ata J, Nickel JC, Thammakraisorn S, Numthavaj P, McEvoy M, Thakkinstan A. Management of chronic prostatitis/chronic pelvic pain syndrome: a systematic review and network meta-analy-sis. JAMA. 2011; 305: 78-86.
15. Nadler RB, Humphrey PA, Smith DS, Catalona WJ, Ratlif TL. Effect of infammaton and benign prostatic hyperplasia on elevated serum prostate specifc antgen levels. J Urol. 1995; 154: 407-413.
16. Nadler RB, Collins MM, Propert KJ, Mikolajc-zyk SD, Knauss JS, Landis JR, et al. Prostate- specific antgen test in diagnostic evaluation of chronic prostatts/chronic pelvic pain syndrome. Urology. 2006; 67: 337-342.
17. Schaefer AJ, Wu SC, Tennenberg AM, Kahn JB. Treatment of chronic bacterial prostatitis with levofoxacin and ciprofoxacin lowers serum prostate specific antigen. J Urol. 2005; 174: 161-164.